Virginia Awards $35.2 Million in Opioid Settlement Grants to 150 Community Projects

The Virginia Opioid Abatement Authority has approved its largest single round of funding since its inception, directing more than $35.2 million to 150 projects across the Commonwealth. The awards, approved by the OAA Grants Committee on June 15, represent a significant expansion of Virginia's strategy to address the ongoing overdose crisis through local, evidence-based interventions.

This funding cycle brings the OAA's total investment to over $150 million since the authority was established by the General Assembly in 2021. The money flows from national settlements with pharmaceutical manufacturers, distributors, and retailers involved in prescription opioids—payments that began in 2022 and are expected to exceed $1.1 billion by 2041.

A Comprehensive Approach to the Crisis

The 150 funded projects span every region of Virginia, from the Appalachian communities in the west to the coastal cities of Hampton Roads. Rather than concentrating resources in a handful of large programs, the OAA has chosen to distribute funding across a diverse portfolio that includes 64 individual distribution projects and 79 cooperative partnerships between multiple jurisdictions.

Senator Todd Pillion, who chairs the OAA Board of Directors, framed the announcement as a validation of local leadership. "Behind every one of these awards is a community that refused to accept the status quo," he said in the authority's press release. "Virginia continues to lead the nation with its opioid settlement fund investments which are doing exactly what they were intended to do—reach people where they are, expand access to the treatment and recovery they need, and give local leaders the resources to solve problems they know better than anyone."

The geographic diversity of the awards reflects Virginia's varied landscape of addiction challenges. Rural counties with limited healthcare infrastructure receive mobile treatment units that can travel to isolated communities. Urban centers like Richmond and Virginia Beach fund peer recovery specialists and youth prevention programs. Suburban jurisdictions in Northern Virginia invest in residential treatment facilities and recovery high schools.

Notable Investments in Treatment and Recovery

Several projects stand out for their innovative approaches or their focus on historically underserved populations. The awards include funding for three regional recovery high schools in Chesapeake, Chesterfield, and Waynesboro—educational environments designed specifically for students working to maintain sobriety while completing their studies. These schools represent a growing recognition that adolescents in recovery need specialized support that traditional schools often cannot provide.

Northern Virginia will see the Commonwealth's first regional residential treatment program for adolescents, addressing a critical gap in services for young people with substance use disorders. The program joins a broader constellation of youth-focused investments that include expanded medication-assisted treatment for adolescents in Fairfax County and teen outreach initiatives in Roanoke City Schools.

The funding round also prioritizes services for pregnant and parenting women, with multiple projects specifically designed to support this population through treatment and into recovery. Research consistently shows that women often face unique barriers to treatment, including childcare responsibilities, stigma, and trauma histories that require gender-responsive care.

Mobile units emerge as a recurring theme throughout the awards. Multiple jurisdictions will deploy vehicles equipped to provide medications for opioid use disorder, therapy, outreach, and harm reduction services directly to communities where transportation barriers prevent people from accessing traditional clinic-based care. These mobile programs address what public health researchers call the "distance death sentence"—the correlation between geographic isolation from treatment and elevated overdose mortality.

Criminal Justice and Harm Reduction

The awards reflect growing recognition that jails and prisons can serve as critical intervention points for people with substance use disorders. Multiple local and regional jail-based treatment programs received funding, including medication-assisted treatment services at facilities in Hampton and Newport News. These programs aim to initiate treatment during incarceration and coordinate continued care upon release, when overdose risk spikes dramatically.

Recovery courts—specialized dockets that combine judicial oversight with treatment and support services—feature prominently in the awards. Programs in Culpeper, Danville-Pittsylvania, Page County, Patrick County, Rockingham, and Smyth County all received funding to expand or maintain their operations. Research from jurisdictions across the country has shown that recovery courts can significantly reduce recidivism while improving treatment outcomes.

Harm reduction services also received substantial support. Richmond City's award for harm reduction vending machines represents an emerging strategy for making naloxone and other supplies available 24/7 without requiring face-to-face interaction. Henrico County's naloxone distribution cabinets for libraries and mental health departments similarly expand access to overdose reversal medication in community settings.

Seven Operation STOP! projects—all renewals—continue targeted overdose prevention efforts in cities and counties where fatal overdoses disproportionately affect Black residents. These programs partner with community-based organizations to implement immediate, short-term interventions while developing longer-term solutions to address racial disparities in overdose mortality.

Workforce and Economic Stability

Recognizing that recovery requires more than clinical treatment, several awards target workforce development and economic stability. New recovery-to-work programs will help individuals in recovery achieve employment and long-term financial stability. These initiatives address a fundamental reality of addiction recovery: without stable housing, income, and purpose, even the most effective treatment often fails to produce lasting results.

A regional stigma reduction campaign also received funding, acknowledging that cultural attitudes toward addiction and recovery can create barriers to treatment-seeking behavior. Despite decades of public health messaging, stigma remains a significant obstacle that prevents many people from acknowledging their substance use and reaching out for help.

The Settlement Framework

Virginia's approach to opioid settlement funds differs from the patchwork systems in many other states. The General Assembly established the Opioid Abatement Authority in 2021 with a clear mandate: oversee the distribution of 55% of Virginia's total settlement funds while ensuring that money reaches communities most affected by the crisis.

The remaining funds are split between direct distributions to cities and counties (30%) and the Commonwealth itself (15%). This structure gives local governments significant autonomy while maintaining statewide coordination through the OAA's grant-making process.

Court orders and state statute restrict how the funds can be used, requiring that they address opioid abatement and remediation efforts. The OAA's public dashboard allows residents to track how money flows from settling companies through the authority to specific local programs, providing a level of transparency that many other states have not achieved.

Context of National Decline

The Virginia announcement arrives as the United States records its third consecutive year of declining overdose deaths. National mortality fell 14% in 2025, with approximately 70,000 Americans dying from drug overdoses compared to more than 110,000 at the pandemic peak in 2022.

Virginia has outpaced the national average in some respects. The state's coordinated response—including Medicaid expansion, harm reduction infrastructure, and now substantial settlement fund investments—has contributed to measurable improvements in overdose mortality. However, challenges remain, particularly in rural areas where treatment access barriers persist and the drug supply continues to evolve with new synthetic opioids and veterinary tranquilizers.

The $35.2 million funding round represents both a celebration of progress and a recognition that sustained investment will be necessary to maintain and extend the gains of recent years. As Senator Pillion's statement suggests, the communities receiving these awards have demonstrated their commitment to addressing the crisis. The funding provides the resources to turn that commitment into measurable outcomes for Virginia residents struggling with substance use disorders.

The awards will begin disbursing for the Fiscal Year 2027 performance period, with programs expected to launch or expand operations in the coming months. For the 150 funded projects, the work of implementation now begins.